Solazyme (SZYM) Tops Q2 Loss Views; Revs Heavy

Solazyme (NASDAQ: SZYM) reported Q2 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.11 million.

For earnings history and earnings-related data on Solazyme (SZYM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Jefferies bullish on Deckers Outdoor, sees HOKA growth slowdown as oversold
• JPMorgan Starts Shinsegae Inc (004170:KS) at Overweight